Quotient Sciences has more than 30 years of experience developing a breadth of formulations across a range of indications. With expertise in simple and complex dosage forms, we have formulated over 1,500 molecules. Our unique track record in clinical research, means we know what it takes to develop formulations across the full development pathway from preclinical to late stage.
From fit-for-purpose preclinical and first-in-human (FIH) dosage forms to optimized drug products for late stage development and market, we work with you to develop the most appropriate formulation based on the physicochemical and biopharmaceutics properties of your molecule.
Operating from our state-of-the-art facilities in the U.S. and U.K. and a with global team of over 200 formulation and analytical scientists, we offer you a comprehensive and tailored formulation development service.
"Quotient Sciences was the idal partner for early clinical development of our new drug class."